- Annual survey recognizes and honors the best employers in Massachusetts
BURLINGTON, Mass., Nov. 17, 2017 -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has been named one of the Top Places to Work in Massachusetts in the 10th annual employee-based survey project conducted by The Boston Globe. The Top Places to Work 2017 will be published in The Boston Globe Magazine on November 19, and the results can also be found online at www.globe.com/topplaces.
The survey identifies and recognizes top workplaces through confidential employee opinions about their company’s direction, execution, connection, management, work, pay and benefits, and engagement. Flexion ranked 11th out of 25 in the small company category which includes organizations that had 50 to 99 employees at the time of the survey.
“We are truly honored to receive this award, which is really a reflection of our employees,” said Michael Clayman, M.D., President and Chief Executive Officer of Flexion. “Our people are the foundation of Flexion’s success, and it is a privilege to lead this remarkable team. They are the reason that Flexion is such a special place to work.”
Flexion is distinguished by five core values that define its culture – focus, ingenuity, tenacity, transparency and fun. These values serve as the pillars upon which co-founders, Dr. Clayman and Neil Bodick, M.D., Ph.D., Chief Scientific Officer, established and grew Flexion.
“Our winning companies are all in on a secret,” said Katie Johnston, The Globe’s Top Places to Work editor. “Treating employees well isn’t that difficult, and the payoff -- increased morale, retention, and productivity -- is huge.”
The rankings in the Top Places to Work are based on confidential survey information collected by Energage (formerly WorkplaceDynamics), an independent company specializing in employee engagement and retention, from nearly 75,060 individuals at 334 Massachusetts organizations. The winners share a few key traits, including offering progressive benefits, ensuring their employees have a voice, and encouraging them to have some fun while doing important work.
About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a specialty pharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with OA, a type of degenerative arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. Flexion was named one of the Boston Business Journal's 2017 Best Places to Work.
About Boston Globe Media Partners LLC
Boston Globe Media Partners, LLC provides news and information, entertainment, opinion and analysis through its multimedia properties. BGMP includes the Boston Globe, BostonGlobe.com, Boston.com, STAT and Globe Direct.
Contacts:
Scott Young
Sr. Director, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
[email protected]
Julie Downs
Manager, Corporate Communications
Flexion Therapeutics, Inc.
T: 781-305-7137
[email protected]


Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 



